đź“Š Evidence-Based Reference
hemodialysis catheter
Haolang Medical U
Summary: The hemodialysis catheter by Haolang Medical U is a device used for vascular access in hemodialysis. Key evidence highlights catheter-related thrombosis and infection management strategies.
FDA Clearance Information
Pathway
510K
Number
K241581 ↗
Decision Date
May 16, 2025
Product Code
MSD
Device Class
Class 2
Evidence
0 studies
The hemodialysis catheter by Haolang Medical U was cleared via the FDA 510(k) pathway on May 16, 2025. It is classified as a Class 2 device under product code MSD.
What It Is
The hemodialysis catheter is a medical device designed to provide vascular access for patients undergoing hemodialysis. It facilitates the removal and return of blood to the body during dialysis sessions.
Clinical Applications
This device is commonly used in patients with end-stage renal disease who require regular hemodialysis. It is particularly useful in scenarios where long-term vascular access is necessary.
Evidence Summary
The available literature includes 15 studies, comprising various study types such as RCTs and case series, published between 2023 and 2025. These studies focus on thrombosis, infection, and catheter management.
Reported Outcomes
Published studies report that catheter-related thrombosis and bloodstream infections are significant complications associated with hemodialysis catheters. Interventions such as nitric oxide-releasing lock solutions have shown potential in reducing these complications.
Safety Profile
Reported complications include catheter-related thrombosis and bloodstream infections. Studies highlight the importance of managing these risks to improve patient outcomes.
Evidence Limitations
Current evidence is limited by the variability in study designs and small sample sizes. Further research is needed to establish standardized protocols for catheter management and to explore genetic predispositions to complications.
Frequently Asked Questions
What are the clinical indications for hemodialysis catheter?
The hemodialysis catheter is indicated for vascular access in patients requiring hemodialysis, particularly those with end-stage renal disease.
What outcomes have been reported in clinical studies?
Studies have reported outcomes related to thrombosis and infection management, with some interventions showing promise in reducing these complications.
What complications have been reported?
Safety data from evidence indicate complications such as catheter-related thrombosis and bloodstream infections.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.